[Risk factors for duration of urinary incontinence after radical prostatectomy]

Nihon Hinyokika Gakkai Zasshi. 2002 Mar;93(3):444-9. doi: 10.5980/jpnjurol1989.93.444.
[Article in Japanese]

Abstract

Purpose: In this study, we examined risk factors for duration of incontinence after radical prostatectomy at our hospital.

Materials and methods: From April 1988 to March 2000, 45 patients with prostate cancer underwent retropubic radical prostatectomy at our hospital. Thirty-eight of 45 patients could be followed up. The patients' age, height, weight, body mass index (BMI), preoperative prostatic specific antigen level, clinical stage, nerve-sparing surgery or none, operation time, bleeding volume, resected prostate weight, cancer positive or negative at surgical margins, postoperative stage, radiation therapy or none, anti-androgen therapy or none, duration of postoperative incontinence, and follow-up period were examined.

Results: All patients had postoperative stress incontinence, and no one had urge incontinence. Medians of duration of postoperative incontinence and follow-up period were 5.5 and 12 months, respectively. When the patients were divided into 2 groups by the value of each parameter, postoperative anti-androgen therapy (chi 2 test, p = 0.0429) and high BMI (> or = 25.0 kg/m2, p = 0.0206) were related to the long duration (> or = 5.5 months) of postoperative incontinence.

Conclusion: These results suggest that common factors are involved in the etiology of prolonged incontinence after radical prostatectomy and genuine stress incontinence in women. Therefore, both body weight control and pelvic floor muscle exercise might be also important for the treatment of incontinence after radical prostatectomy.

Publication types

  • English Abstract

MeSH terms

  • Aged
  • Aged, 80 and over
  • Androgen Antagonists / therapeutic use
  • Body Mass Index
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Prostatectomy*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / surgery
  • Risk Factors
  • Urinary Incontinence, Stress / etiology*

Substances

  • Androgen Antagonists